SCHEMBL1760199

SCHEMBL1760199

O=C1/C=C\N=C/C=C\N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5967952 1.00 — —
SCHEMBL8762693 0.67 — —
SCHEMBL8762698 0.67 — —
SCHEMBL616019 0.64 — —
Hydrochloric Acid SCHEMBL28869240 0.61 — —
SCHEMBL6542616 0.59 — —
SCHEMBL222490 0.59 — —
SCHEMBL9934605 0.58 — —
SCHEMBL9934609 0.58 — —
SCHEMBL9933497 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937077-B1 PYRIDONE-FUSED AZABICYCLIC- OR CYTISINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN ADDICTION THERAPY PFIZER (US) 2006-05-17 — — EP claimed
US-8765728-B2 [1,5]-diazocin derivatives MELLITECH (FR) 2014-07-01 — — US disclosed
EP-2501685-A1 [1,5]-DIAZOCIN DERIVATIVES Mellitech (FR) 2012-09-26 — — EP disclosed
US-20120225892-A1 [1,5]-Diazocin Derivatives MELLITECH (FR) 2012-09-06 — — US disclosed
WO-2011058193-A1 [1,5]-DIAZOCIN DERIVATIVES MELLITECH (FR) 2011-05-19 — — WO disclosed
Send feedback